Literature DB >> 3371374

The optimum time for tumour imaging with thallium-201.

A Sehweil1, J H McKillop, G Ziada, M Al-Sayed, H Abdel-Dayem, Y T Omar.   

Abstract

Following the intravenous injection of 75 MBq 201Tl-chloride we have assessed the uptake kinetics in the myocardium and in the primary tumour in 56 patients with lung cancer, 26 with breast cancer and 13 with mediastinal lymphoma. The time of maximal tumour uptake ranged from 8-20 min post-injection and did not differ significantly between lung cancer (mean +/- SD = 11.9 +/- 3.34 min), breast cancer (11.21 +/- 1.88 min) and lymphoma (11.76 +/- 3.25 min). The time of maximum cardiac uptake of 201Tl was 11.61 +/- 3.25 min. There was no significant washout of 201Tl from the tumours in the first hour after injection in the various malignant lesions studied. The time of maximal tumour to background activity was 18.3 +/- 0.59 min for lung cancer, 13.0 +/- 1.16 min for breast cancer and 16.7 +/- 1.04 min for lymphoma. The time course of 201Tl uptake in the tumours suggests that the mechanism of uptake is similar to that in the myocardium. The optimal time of 201Tl tumour imaging is from 20-60 min following injection and did not differ in various tumours studied.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371374     DOI: 10.1007/bf00256629

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  TUMOR SCANNING WITH RADIOACTIVE 131-CESIUM.

Authors:  N D CHARKES; D M SKLAROFF; J GERSHON-COHEN; R E CANTOR
Journal:  J Nucl Med       Date:  1965-04       Impact factor: 10.057

2.  Thallium-201 for medical use. I.

Authors:  E Lebowitz; M W Greene; R Fairchild; P R Bradley-Moore; H L Atkins; A N Ansari; P Richards; E Belgrave
Journal:  J Nucl Med       Date:  1975-02       Impact factor: 10.057

3.  Thallium-201-chloride thyroid scintigraphy to evaluate benign and/or malignant nodules: usefulness of the delayed scan.

Authors:  H Ochi; H Sawa; T Fukuda; Y Inoue; H Nakajima; Y Masuda; T Okamura; Y Onoyama; S Sugano; H Ohkita; Y Tei; K Kamino; Y Kobayashi
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

4.  Thallium-201 for medical use. II: Biologic behavior.

Authors:  P R Bradley-Moore; E Lebowitz; M W Greene; H L Atkins; A N Ansari
Journal:  J Nucl Med       Date:  1975-02       Impact factor: 10.057

5.  Comparison of Tl-201 chloride and Ga-67 citrate scintigraphy in the diagnosis of thyroid tumor: concise communication.

Authors:  O Senga; M Miyakawa; H Shirota; M Makiuchi; K Yano; M Miyazawa; M Takizawa
Journal:  J Nucl Med       Date:  1982-03       Impact factor: 10.057

6.  Thallium 201 chloride uptake in tumours, a possible complication in heart scintigraphy.

Authors:  P H Cox; A J Belfer; W B van der Pompe
Journal:  Br J Radiol       Date:  1976-09       Impact factor: 3.039

7.  Mechanisms for localization of radiopharmaceuticals in neoplasms.

Authors:  H S Winchell
Journal:  Semin Nucl Med       Date:  1976-10       Impact factor: 4.446

8.  Thallium-201 brain tumor imaging: a comparative study with pathologic correlation.

Authors:  W D Kaplan; T Takvorian; J H Morris; C L Rumbaugh; B T Connolly; H L Atkins
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

9.  Mechanism of thallium extraction in pump perfused canine hearts.

Authors:  R D Carlin; K M Jan
Journal:  J Nucl Med       Date:  1985-02       Impact factor: 10.057

10.  Relation between 201Tl to 67Ga uptake ratio and histological type in primary lung cancer.

Authors:  T Togawa; A Suzuki; K Kato; Y Higuchi; H Moriya; K Hoshi; K Kimura; T Kawaguchi
Journal:  Eur J Cancer Clin Oncol       Date:  1985-08
  10 in total
  9 in total

1.  Demonstration of non-Hodgkin's lymphoma by dual radionuclide myocardial perfusion imaging.

Authors:  M C Cohen; J K Rastegar; R A DeSilva; T C Hill
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

2.  The use of technetium-99m sestamibi to indicate breast cancer invasiveness.

Authors:  P Bourgeois
Journal:  Eur J Nucl Med       Date:  1995-06

3.  The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.

Authors:  C I Caluser; H M Abdel-Dayem; H A Macapinlac; A Scott; J H Healey; A Huvos; H Kalaigian; S D Yeh; S M Larson
Journal:  Eur J Nucl Med       Date:  1994-11

4.  Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomography.

Authors:  Y Tokuchi; H Isobe; H Takekawa; T Hanada; T Ishida; S Ogura; K Itoh; M Furudate; K Saito; Y Kawakami
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

Review 5.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

6.  Abnormal uptake of technetium-99m hexakis-2-methoxyisobutylisonitrile in a primary cardiac lymphoma.

Authors:  G Medolago; G Virotta; A Pitì; M Tespili; F D'Adda; M R Rottoli; B Comotti; T Motta; C Orlandi; C Bertocchi
Journal:  Eur J Nucl Med       Date:  1992

7.  Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas.

Authors:  L Kostakoglu; D M Panicek; C R Divgi; J Botet; J Healey; S M Larson; H M Abdel-Dayem
Journal:  Eur J Nucl Med       Date:  1995-11

8.  Mechanism of 201Tl uptake in tumours.

Authors:  A M Sehweil; J H McKillop; R Milroy; R Wilson; H M Abdel-Dayem; Y T Omar
Journal:  Eur J Nucl Med       Date:  1989

9.  Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours.

Authors:  R A Dierckx; J J Martin; A Dobbeleir; R Crols; I Neetens; P P De Deyn
Journal:  Eur J Nucl Med       Date:  1994-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.